Back to search

Netherlands· NL-76e63c9f39f8

Bromazepam Sandoz 6, tabletten 6 mg

A bromazepam product containing bromazepam, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC N05BA08

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBromazepam Sandoz 6, tabletten 6 mgATCN05BA08REGISTER NO.NL-76e63c9f39f8PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Bromazepam is registered in 13 of 19 countries.

Countries holding a registration under ATC N05BA08 (bromazepam), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Bromazepam · ATC N05BA08

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bromazepam costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.11 in France to $1.17 in Switzerland — a ×11 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Bromazepam · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.17
  • FR France$0.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BROMAZEPAM
Manufacturer
Sandoz B.V.
Country
Netherlands (NL)
ATC code
N05BA08
ATC class
Bromazepam
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    12992

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

49 interactions on record for bromazepam.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bromazepam · interactions on record

49 records

49 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Bromazepam in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromazepam products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Bromazepam G.L., Bromazepam Genericon
  • Belgium · Bromazepam Eg, Bromazepam Sandoz
  • Bulgaria · Брелакс, Лексотан
  • Cyprus · Akamon, Amant
  • Czechia · Becalen, Bromazepam Medreg
  • Germany · Bromazanil, Bromazep Ct Abz-Pharma
  • Denmark · Lexotan
  • Estonia · Bromazepam Lannacher
  • Spain · Bromazepam Kern Pharma, Bromazepam Normon
  • France · Bromazepam Arrow, Bromazepam Biogaran
  • Greece · Lexotanil, Notorium
  • Croatia · Bromazepam Inn-Farm, Lexaurin
  • Ireland · Lexotan
  • Italy · Bromazepam Abc, Bromazepam Accord
  • Lithuania · Bromazepam Lannacher, Lexotanil
  • Luxembourg · Bromazepam Eg, Lexotan
  • Latvia · Bromazepam Lannacher, Lexotanil
  • Malta · Akamon, Lexilium
  • Poland · Bromox, Lexotan
  • Portugal · Bromalex, Bromazepam Pharmakern
  • Romania · Bromazepam Arena, Bromazepam Lph Labormed
  • Slovenia · Bromazepam Inn-Farm, Lexaurin
  • Slovakia · Bromazepam Medochemie, Bromazepam Medreg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/229cd144-7f5b-4495-b249-90b1b30adb6c
GET /v1/drugs/229cd144-7f5b-4495-b249-90b1b30adb6c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h12992_smpc.pdf",
  "strength": null,
  "atc_label": "Bromazepam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg12992",
  "excipients": [
    "CARMELLOSE NATRIUM (E 466)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CHINOLINEGEEL (E 104)",
    "GELATINE (E 441)",
    "INDIGOKARMIJN (E 132)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "STEARINEZUUR (E 570)",
    "TALK (E 553b)"
  ],
  "substances": [
    "BROMAZEPAM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h12992.pdf",
  "authorised_at": "1987/07/22",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "12992",
  "additional_monitoring": "N"
}

See everything about bromazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.